Ancora Advisors’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$220K Sell
3,187
-50
-2% -$3.45K ﹤0.01% 689
2025
Q1
$225K Buy
3,237
+425
+15% +$29.5K 0.01% 680
2024
Q4
$242K Buy
2,812
+319
+13% +$27.4K 0.01% 662
2024
Q3
$297K Buy
2,493
+325
+15% +$38.7K 0.01% 602
2024
Q2
$309K Buy
2,168
+65
+3% +$9.28K 0.01% 574
2024
Q1
$270K Buy
2,103
+181
+9% +$23.2K 0.01% 601
2023
Q4
$199K Sell
1,922
-616
-24% -$63.7K ﹤0.01% 646
2023
Q3
$231K Hold
2,538
0.01% 613
2023
Q2
$205K Hold
2,538
0.01% 626
2023
Q1
$202K Buy
2,538
+66
+3% +$5.25K 0.01% 625
2022
Q4
$167K Hold
2,472
﹤0.01% 688
2022
Q3
$123K Buy
2,472
+100
+4% +$4.98K ﹤0.01% 813
2022
Q2
$132K Sell
2,372
-164
-6% -$9.13K ﹤0.01% 849
2022
Q1
$141K Hold
2,536
﹤0.01% 898
2021
Q4
$142K Hold
2,536
﹤0.01% 909
2021
Q3
$122K Hold
2,536
﹤0.01% 900
2021
Q2
$106K Sell
2,536
-888
-26% -$37.1K ﹤0.01% 878
2021
Q1
$115K Buy
3,424
+1,524
+80% +$51.2K ﹤0.01% 824
2020
Q4
$66K Sell
1,900
-1,528
-45% -$53.1K ﹤0.01% 808
2020
Q3
$119K Buy
3,428
+464
+16% +$16.1K ﹤0.01% 672
2020
Q2
$97K Sell
2,964
-60
-2% -$1.96K ﹤0.01% 700
2020
Q1
$91K Hold
3,024
﹤0.01% 768
2019
Q4
$88K Buy
+3,024
New +$88K ﹤0.01% 788
2018
Q4
Sell
-4,024
Closed -$95K 1008
2018
Q3
$95K Buy
+4,024
New +$95K ﹤0.01% 764
2017
Q1
Sell
-9,500
Closed -$170K 939
2016
Q4
$170K Buy
+9,500
New +$170K 0.01% 578